...BioVentures; Invesco; Lloyds Development Capital; GeneChem Management; Merifin Capital; Merlin Biosciences; Noble Grossart; Northern Ventures; Quester Capital...

...Venture Fund; Global Life Science Ventures; Gilde Investment Management; Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...

...Ventures and Gilde Investment Management. Other investors included DVC Deutsche Venture Capital; ABN AMRO Capital; Quester Capital...

...the spring to raise £15 million ($25 million). Other investors include Abingworth; JP Morgan Partners; Quester Capital...

...Partners. Other investors in the preclinical allergy and autoimmune company included Abingworth; JP Morgan Partners; Quester Capital...

...company Oxxon Pharmaccines raised £15 million ($23.4 million) in a series B round led by Quester Capital...

...Pharmaccines (Oxford, U.K.) raised L15 million ($23.4 million) in a series B round led by Quester Capital...

...raised £11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...

...raised L11.5 million ($17.9 million) in a private round led by Advent Venture Partners and Quester Capital...

...61.6% of Celmed. In the U.K., Johnson & Johnson Development joined Avlar BioVentures; 3i; and Quester Capital...